Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
22.68
+1.12 (5.19%)
At close: Jul 30, 2026, 4:00 PM EDT
22.90
+0.22 (0.97%)
After-hours: Jul 30, 2026, 7:34 PM EDT
Monte Rosa Therapeutics Market Cap
Monte Rosa Therapeutics has a market cap or net worth of $1.92 billion as of July 30, 2026. Its market cap has increased by 492.19% in one year.
Market Cap
1.92B
Enterprise Value
1.29B
1-Year Change
492.19%
Ranking
Category
Stock Price
$22.68
ChartMarket Cap Chart
Since the IPO on June 24, 2021, Monte Rosa Therapeutics's market cap has increased from $845.31M to $1.92B, an increase of 126.66%. That is a compound annual growth rate of 17.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 1.92B | 87.65% |
| Dec 31, 2025 | 1.02B | 139.48% |
| Dec 31, 2024 | 426.37M | 50.74% |
| Dec 29, 2023 | 282.85M | -23.21% |
| Dec 30, 2022 | 368.32M | -61.22% |
| Dec 31, 2021 | 949.65M | 12.34% |
| Jun 24, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UroGen Pharma | 2.00B |
| Nanobiotix | 1.98B |
| Tyra Biosciences | 1.97B |
| Agios Pharmaceuticals | 1.95B |
| GH Research | 1.95B |
| Aurinia Pharmaceuticals | 1.93B |
| Forte Biosciences | 1.88B |
| Taysha Gene Therapies | 1.88B |